Rounds
Editorial team

Yemi Adebayo

Markets Reporter
Fictional contributor
New York, New Yorkhe/him

About Yemi

Yemi Adebayo is a markets reporter at Rounds covering how public equities — biotech, medtech, payors, and digital-health platforms — react to deals, FDA decisions, and clinical readouts.

He spent five years as a sell-side equity analyst at Redfern Securities covering small- and mid-cap biotech before moving to journalism. His morning notes are read by 12,000+ buy-side analysts and PMs.

Yemi specializes in financial analysis.

Highlights

  • Trained in financial analysis.
  • Recognized in a fictional small-cap research ranking.
  • 12,000+ subscribers to morning markets note.

Experience

  1. 2024 — Present
    Markets Reporter
    Rounds
  2. 2019 — 2024
    Senior Equity Analyst, Biotech
    Redfern Securities
  3. 2016 — 2019
    Equity Research Associate
    Ashbrook Research

Recent stories by Yemi

Deals & CapitalDemo

Halvorsen Pharma pays $2.1B for Calder Bio. Why the price held.

Yemi Adebayo · 4 min
Two interlocking paper envelopes joined by a paper clip